Chadwick R. Johr, MD (@drchadjohr) 's Twitter Profile
Chadwick R. Johr, MD

@drchadjohr

Sharing my perspectives on #Sjögren's. Director, Penn Sjögren's Center. Former board of directors @SjogrensOrg. #Rheum. Opinions my own. Not medical advice.

ID: 1519123323321339906

calendar_today27-04-2022 01:17:55

531 Tweet

1,1K Followers

168 Following

Donald Thomas, MD (@lupuscyclopedia) 's Twitter Profile Photo
Donald Thomas, MD
@lupuscyclopedia

a year ago

🔥 Afraid of hydroxychloroquine (HCQ, Plaquenil)? Not taking your HCQ regularly? Look at this simple tool to see the impact of taking HCQ regularly: 👉CLICK: hcqsafe.medicine.wisc.edu/hcq-tool/ Click on the top left of the website on the areas like "Organ Damage" or "Death," and you will

🔥 Afraid of hydroxychloroquine (HCQ, Plaquenil)? Not taking your HCQ regularly? Look at this simple tool to see the impact of taking HCQ regularly: 👉CLICK: hcqsafe.medicine.wisc.edu/hcq-tool/ Click on the top left of the website on the areas like "Organ Damage" or "Death," and you will
Chadwick R. Johr, MD (@drchadjohr) 's Twitter Profile Photo
Chadwick R. Johr, MD
@drchadjohr

5 months ago

Proud (and surprised!) to be this years recipient of the Blockley-Osler Award almanac.upenn.edu/articles/2025-… "Created in 1987 by the Blockley Section of the Philadelphia College of Physicians, this award is given annually to a member of the faculty at an affiliated hospital for

Dysautonomia Intl. (@dysautonomia) 's Twitter Profile Photo
Dysautonomia Intl.
@dysautonomia

a month ago

Good news for dysautonomia patients w/ Sjogren's! Ianalumab is the 1st immunotherapy to have successful Phase 3 trials in Sjogren's, which means it has a real chance to obtain FDA approval. Sjogren's is the 2nd most common cause of autonomic neuropathy. novartis.com/news/media-rel…